Tianjin University has successfully developed an oral vaccine to protect against CODV 19 – Global Times
|The Global Times says that Tianjin University has successfully developed an oral vaccine to protect against CODV 19. Huang Jinhai, the professor who led the project, has taken four doses without any side effects. The team is now looking for partners to promote clinical trials.
As far as a cure, there are still no approved treatments. Health workers have been trying everything from steroids and antibodies to drugs normally intended for HIV and influenza. But because these treatments have been dispensed on a case-by-case basis, without any rigorous, centralized tracking of results, it’s has proved difficult to know if any of them are effective against the new disease.
In any case, the good news is welcomed and slow progress is still progressing as far as the markets will be concerned. We are seeing a slight correction in risk appetite in Asia today following a blood bath overnight.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.